| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |